Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 13


The increase in cancer prevalence and hospital burden in Western Australia, 1992-2011.

Maxwell S, O'Leary P, Slevin T, Moorin R.

Popul Health Metr. 2014 Dec 19;12(1):33. doi: 10.1186/s12963-014-0033-x. eCollection 2014.


Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders.

Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC.

Bone Marrow Transplant. 2015 Mar;50(3):367-74. doi: 10.1038/bmt.2014.269. Epub 2014 Dec 1.


Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types.

Dal Maso L, Guzzinati S, Buzzoni C, Capocaccia R, Serraino D, Caldarella A, Dei Tos AP, Falcini F, Autelitano M, Masanotti G, Ferretti S, Tisano F, Tirelli U, Crocetti E, De Angelis R; AIRTUM Working group.

Ann Oncol. 2014 Nov;25(11):2251-60. doi: 10.1093/annonc/mdu383. Epub 2014 Aug 22.


Modeling delay to diagnosis for amyotrophic lateral sclerosis: under reporting and incidence estimates.

Rocchetti I, Taruscio D, Pierannunzio D.

BMC Neurol. 2012 Dec 23;12:160. doi: 10.1186/1471-2377-12-160.


Projections of cancer prevalence in the United Kingdom, 2010-2040.

Maddams J, Utley M, Møller H.

Br J Cancer. 2012 Sep 25;107(7):1195-202. doi: 10.1038/bjc.2012.366. Epub 2012 Aug 14.


Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry.

Pavlík T, Májek O, Mužík J, Koptíková J, Slavíček L, Fínek J, Feltl D, Vyzula R, Dušek L.

BMC Public Health. 2012 Feb 10;12:117. doi: 10.1186/1471-2458-12-117.


Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty.

van Baal PH, Engelfriet PM, Hoogenveen RT, Poos MJ, van den Dungen C, Boshuizen HC.

BMC Public Health. 2011 Mar 15;11:163. doi: 10.1186/1471-2458-11-163.


Getting cancer prevalence right: using state cancer registry data to estimate cancer survivors.

Carpenter WR, Yeh WS, Wobker SE, Godley PA.

Cancer Causes Control. 2011 May;22(5):765-73. doi: 10.1007/s10552-011-9749-0. Epub 2011 Mar 1.


Prevalence of breast carcinoma in situ in the United States.

Sprague BL, Trentham-Dietz A.

JAMA. 2009 Aug 26;302(8):846-8. doi: 10.1001/jama.2009.1211. No abstract available.


Cancer prevalence in the United Kingdom: estimates for 2008.

Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, Møller H.

Br J Cancer. 2009 Aug 4;101(3):541-7. doi: 10.1038/sj.bjc.6605148. Epub 2009 Jun 30.


How many people have had a myocardial infarction? Prevalence estimated using historical hospital data.

Manuel DG, Lim JJ, Tanuseputro P, Stukel TA.

BMC Public Health. 2007 Jul 24;7:174.


Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid.

Mullins CD, Cooke JL Jr, Wang J, Shaya FT, Hsu DV, Brooks S.

J Natl Med Assoc. 2004 Jun;96(6):809-16.


Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations.

Panico S, Galasso R, Celentano E, Ciardullo AV, Frova L, Capocaccia R, Trevisan M, Berrino F.

Am J Public Health. 2000 Sep;90(9):1397-402.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk